Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02975024
Other study ID # 3/2013
Secondary ID
Status Completed
Phase
First received November 16, 2016
Last updated April 17, 2018
Start date November 2016
Est. completion date December 2017

Study information

Verified date April 2018
Source Semmelweis University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Apply the LSCI for follow-up the postoperative microcirculation after surgical procedures to enlarge keratinized gingiva in order to characterize the kinetics of the blood flow changes during wound healing in human subjects.


Description:

Vestibuloplasty is the common name of those procedures designed to widen the zone of attached gingiva. The apically repositioned split thickness flap with a xenogeneic collagen matrix or with a combination of strip gingival graft and a xenogeneic collagen matrix are frequently used surgical techniques, however no data are available, how these graft tissues affect the microcirculation of the healing gingiva.

LSCI is a non-invasive, two dimensional method to evaluate microcirculation of different tissues. This new method let us monitor the entire surgical area real-time during the healing period.

The aim of the present study is to define blood flow patterns, which might characterize the wound healing of such surgical procedures during the first 6 months of healing in order to facilitate treatment.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Ages Eligible for Study: 18 Years to 45 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• clinical diagnosis of inadequate width of keratinized gingiva at the mandibular front region

Exclusion Criteria:

- pregnancy

- heavy smoking

- general diseases

- taking medications or having treatments which have an effect on mucosal healing in general (e.g. steroids, anti-inflammatory drugs)

- taking any other medications in the last three months (except contraceptives)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
laser speckle contrast imaging of the oral mucosa
Non-invasive method to measure tissue blood perfusion applied for oral mucosa
wound fluid measurement
Wound fluid at the wound margin is collected using filter strip and volumetrically measured by Periotron 8010 instrument.
quantitative determination of VEGF
For the quantitative determination of VEGF in the fourth day wound fluid sample the Human VEGF Quantikine ELISA Kit will be used.

Locations

Country Name City State
Hungary Janos Vag Budapest

Sponsors (2)

Lead Sponsor Collaborator
Semmelweis University Hungarian Scientific Research Fund

Country where clinical trial is conducted

Hungary, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative blood flow changes of the oral mucosa Blood flow changes are measured by Laser Speckle Contrast Imager (LSCI) after mandibular vestibuloplasty. The scale is an arbitrary unit (0-3000 LSPU) and the relative changes to the surgically unaffected surrounding mucosa measurements are calculated. Postoperative follow-up time-points are: 1, 2, 3, 4, 5, 6, 7, 9, 11, 14, 21, 28 days, and 2, 3, 4, 5, 6 months. The apically repositioned split thickness flap is combined either with a Mucograft alone, or with a combination of autologous strip gingival graft and Mucograft. The differences in postoperative blood flow changes are compared between the two surgical techniques. 6 months after surgery
Secondary Wound fluid volume measurement Wound fluid sample is collected using a filter strip to withdraw the fluid around the wound. The filter strip is then inserted into Periotron 8010 instrument to score the volume on the paper. Scores are measured in an arbitrary unit. Postoperative follow-up time-points are: 1, 2, 3, 4, 5, 6, 7, 9, 11, 14 days. The apically repositioned split thickness flap is combined either with a Mucograft alone, or with a combination of autologous strip gingival graft and Mucograft. The differences in postoperative wound fluid changes are compared between the two surgical techniques. 14 days after surgery
Secondary Evaluation of the periodontal parameters at teeth at the surgical site: a composite outcome measure consisting of multiple measures. Periodontal parameters are evaluated using a periodontal probe and will be expressed in mm. The following will be assessed at each tooth at the surgical site: probing depth, depth and width of recession, papilla height, and width and thickness of the keratinized gingiva. Surgical area is also measured apico-coronally and mesio-distally, during the whole follow-up period. Pre- and six month postoperative
Secondary Quantitative determination of Vascular Endothelial Growth Factor (VEGF) of the wound fluid Wound fluid sample for VEGF is collected at the fourth postoperative day. For the quantitative determination of VEGF in samples the Human VEGF Quantikine ELISA Kit will be used. The apically repositioned split thickness flap is combined either with a Mucograft alone, or with a combination of autologous strip gingival graft and Mucograft. The differences in postoperative wound fluid level of VEGF (expressed in conc pg/mL) are compared between the two surgical techniques. 4 days after surgery